Patient with severe alopecia areata with hair regrowth and text reading "Significant hair regrowth was seen in under 6 months". See safety info.

Patient with severe alopecia areata with hair regrowth and text reading "Significant hair regrowth was seen in under 6 months". See safety info.

Results with LITFULO

Patient portrayal.
style
No-padding-bottom-tablet

LITFULO may give you significant scalp hair regrowth

Graphic detailing a clinical study that show 23 percent of adults and adolescents taking LITFULO saw 80 percent or more scalp hair coverage vs 1.6 percent on placebo. Graphic detailing a clinical study that show 23 percent of adults and adolescents taking LITFULO saw 80 percent or more scalp hair coverage vs 1.6 percent on placebo.

*Compared with 1.6% on placebo. And, 13.4% of people taking LITFULO saw 90% or more scalp hair coverage vs 1.5% on placebo.
†Compared with 1.6% on placebo.

How was LITFULO studied?

In a 48-week, randomized, double-blind, placebo-controlled clinical study, participants (261 people, ages 12+, who had lost at least half of their scalp hair due to alopecia areata) took either LITFULO or placebo (an inactive pill). Safety and effectiveness have not been studied in people under 12 years of age. Results were measured at 24 weeks. Find out more information about the study.

In the clinical trials, the most common side effects of LITFULO included:

headache; diarrhea; acne; rash; hives; inflamed hair pores (folliculitis); fever; eczema; dizziness; shingles; decreased red blood cell counts; and mouth sores, redness and swelling of the lining of your mouth. These are not all of the possible side effects of LITFULO. Always talk to your doctor about side effects and learn more about LITFULO safety.

Before and after taking LITFULO

Clinical study photos show examples of hair regrowth observed on the scalp of actual adult or adolescent patients with alopecia areata taking LITFULO. Studies show that the safety and effectiveness of LITFULO were consistent between adults and adolescents.

Individual results may vary. Not everyone will respond to LITFULO.

Please update images from /assets/images/results-in-adolescents folder

Update some text labels from /placeholders.xlsx

style
Before-after-taking-litfulo , bg-teal-10, radius-tablet-20
id
Before-after-taking-litfulo
It was really incredible seeing [my hair] grow and progress month after month.
Jessica, LITFULO patient.

Additional LITFULO data

After regrowth was measured at Week 24, participants continued taking LITFULO (50 mg) through Week 48. Those still on placebo at Week 24 were switched to LITFULO (50 mg), but data from this subset of patients are not reflected below.

Scalp hair response at Week 48

At Week 48, the percentage of patients with 80% or more scalp hair coverage was measured. This additional analysis of patients was not specifically designed to find the differences between LITFULO and placebo.

At Week 24: 23% of people on LITFULO saw 80% or more scalp hair coverage.

At Week 48: 43% of people taking LITFULO saw 80% or more scalp hair coverage.

A real LITFULO patient, Jessica.

LITFULO patient.

Real stories

Watch patients and experts share their experiences with severe alopecia areata and LITFULO.

Watch now

How does LITFULO work?

Let's go beneath the surface to find out how LITFULO works in the body.

See how Litfulo works

Talk to a dermatologist about LITFULO

Prepare for your dermatologist appointment with a doctor discussion guide.

Create your guide